Cargando…

Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?

Cognitive dysfunction is one of the most severe nonmotor symptoms of nigrostriatal impairment. This occurs as a result of profound functional and morphological changes of different neuronal circuits, including modifications in the plasticity and architecture of hippocampal synapses. Such alterations...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera, Macarena L., Deza-Ponzio, Romina, Ghersi, Marisa S., de la Villarmois, Emilce A., Virgolini, Miriam B., Pérez, Mariela F., Molina, Victor A., Bellini, María J., Hereñú, Claudia B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263115/
https://www.ncbi.nlm.nih.gov/pubmed/32466659
http://dx.doi.org/10.1177/1759091420925977
_version_ 1783540744010596352
author Herrera, Macarena L.
Deza-Ponzio, Romina
Ghersi, Marisa S.
de la Villarmois, Emilce A.
Virgolini, Miriam B.
Pérez, Mariela F.
Molina, Victor A.
Bellini, María J.
Hereñú, Claudia B.
author_facet Herrera, Macarena L.
Deza-Ponzio, Romina
Ghersi, Marisa S.
de la Villarmois, Emilce A.
Virgolini, Miriam B.
Pérez, Mariela F.
Molina, Victor A.
Bellini, María J.
Hereñú, Claudia B.
author_sort Herrera, Macarena L.
collection PubMed
description Cognitive dysfunction is one of the most severe nonmotor symptoms of nigrostriatal impairment. This occurs as a result of profound functional and morphological changes of different neuronal circuits, including modifications in the plasticity and architecture of hippocampal synapses. Such alterations can be implicated in the genesis and progression of dementia associated with neurodegenerative diseases including Parkinson-like symptoms. There are few studies regarding cognitive changes in nigrostriatal animal models. The aim of this study was to characterize the onset of memory deficit after induction of neurotoxicity with 6-hydroxydopamine (6-OHDA) and its correlation with hippocampal dysfunction. For this, we bilaterally microinjected 6-OHDA in dorsolateral Caudate-Putamen unit (CPu) and then, animals were tested weekly for working memory, spatial short-term memory, and motor performance. We evaluated tyrosine hydroxylase (TH) as a dopamine marker, aldehyde dehydrogenase 2 (ALDH2), a mitochondria detoxification enzyme and astrocyte glial fibrillar acid protein (GFAP) an immunoreactivity marker involved in different areas: CPu, substantia nigra, prefrontal cortex, and hippocampus. We observed a specific prefrontal cortex and nigrostriatal pathway TH reduction while ALDH2 showed a decrease-positive area in all the studied regions. Moreover, GFAP showed a specific CPu decrease and hippocampus increase of positively stained area on the third week after toxicity. We also evaluated the threshold to induce long-term potentiation in hippocampal excitability. Our findings showed that reduced hippocampal synaptic transmission was accompanied by deficits in memory processes, without affecting motor performance on the third-week post 6-OHDA administration. Our results suggest that 3 weeks after neurotoxic administration, astrocytes and ALDH2 mitochondrial enzyme modifications participate in altering the properties that negatively affect hippocampal function and consequently cognitive behavior.
format Online
Article
Text
id pubmed-7263115
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72631152020-06-10 Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved? Herrera, Macarena L. Deza-Ponzio, Romina Ghersi, Marisa S. de la Villarmois, Emilce A. Virgolini, Miriam B. Pérez, Mariela F. Molina, Victor A. Bellini, María J. Hereñú, Claudia B. ASN Neuro Original Paper Cognitive dysfunction is one of the most severe nonmotor symptoms of nigrostriatal impairment. This occurs as a result of profound functional and morphological changes of different neuronal circuits, including modifications in the plasticity and architecture of hippocampal synapses. Such alterations can be implicated in the genesis and progression of dementia associated with neurodegenerative diseases including Parkinson-like symptoms. There are few studies regarding cognitive changes in nigrostriatal animal models. The aim of this study was to characterize the onset of memory deficit after induction of neurotoxicity with 6-hydroxydopamine (6-OHDA) and its correlation with hippocampal dysfunction. For this, we bilaterally microinjected 6-OHDA in dorsolateral Caudate-Putamen unit (CPu) and then, animals were tested weekly for working memory, spatial short-term memory, and motor performance. We evaluated tyrosine hydroxylase (TH) as a dopamine marker, aldehyde dehydrogenase 2 (ALDH2), a mitochondria detoxification enzyme and astrocyte glial fibrillar acid protein (GFAP) an immunoreactivity marker involved in different areas: CPu, substantia nigra, prefrontal cortex, and hippocampus. We observed a specific prefrontal cortex and nigrostriatal pathway TH reduction while ALDH2 showed a decrease-positive area in all the studied regions. Moreover, GFAP showed a specific CPu decrease and hippocampus increase of positively stained area on the third week after toxicity. We also evaluated the threshold to induce long-term potentiation in hippocampal excitability. Our findings showed that reduced hippocampal synaptic transmission was accompanied by deficits in memory processes, without affecting motor performance on the third-week post 6-OHDA administration. Our results suggest that 3 weeks after neurotoxic administration, astrocytes and ALDH2 mitochondrial enzyme modifications participate in altering the properties that negatively affect hippocampal function and consequently cognitive behavior. SAGE Publications 2020-05-28 /pmc/articles/PMC7263115/ /pubmed/32466659 http://dx.doi.org/10.1177/1759091420925977 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Paper
Herrera, Macarena L.
Deza-Ponzio, Romina
Ghersi, Marisa S.
de la Villarmois, Emilce A.
Virgolini, Miriam B.
Pérez, Mariela F.
Molina, Victor A.
Bellini, María J.
Hereñú, Claudia B.
Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
title Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
title_full Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
title_fullStr Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
title_full_unstemmed Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
title_short Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
title_sort early cognitive impairment behind nigrostriatal circuit neurotoxicity: are astrocytes involved?
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263115/
https://www.ncbi.nlm.nih.gov/pubmed/32466659
http://dx.doi.org/10.1177/1759091420925977
work_keys_str_mv AT herreramacarenal earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved
AT dezaponzioromina earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved
AT ghersimarisas earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved
AT delavillarmoisemilcea earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved
AT virgolinimiriamb earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved
AT perezmarielaf earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved
AT molinavictora earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved
AT bellinimariaj earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved
AT herenuclaudiab earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved